MCID: CHL039
MIFTS: 34

Choledocholithiasis malady

Category: Gastrointestinal diseases

Aliases & Classifications for Choledocholithiasis

About this section

Aliases & Descriptions for Choledocholithiasis:

Name: Choledocholithiasis 11 50 39 13 68

Classifications:



External Ids:

Disease Ontology11 DOID:11755
MeSH39 D042883

Summaries for Choledocholithiasis

About this section
MalaCards based summary: Choledocholithiasis is related to cholelithiasis and gastric neuroendocrine tumor type 1. An important gene associated with Choledocholithiasis is GPT (Glutamic--Pyruvic Transaminase), and among its related pathways are FOXA2 and FOXA3 transcription factor networks and Lysosome. Affiliated tissues include liver, testes and heart.

Related Diseases for Choledocholithiasis

About this section

Diseases related to Choledocholithiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 99)
idRelated DiseaseScoreTop Affiliating Genes
1cholelithiasis10.3
2gastric neuroendocrine tumor type 110.3GPT, SLC17A5
3radiation induced cancer10.2GPT, SLC17A5
4familial progressive hyperpigmentation10.2F2, GPT
5cholangitis10.2
6megaloblastic anemia10.2GPT, SLC17A5
7maxillary sinusitis10.2F2, GPT
8anhidrosis10.2ABCB4, CTSC
9jejunal neuroendocrine tumor10.1ALPP, GPT
10nondystrophic myotonia10.1ALB, F2
11periodontitis 1, juvenile10.1CTSC, SLC17A5
12renal artery disease10.1ALB, UGT1A1
13freiberg's disease10.1ALB, F2
14pulpitis10.1F2, SLC17A5
15pharynx carcinoma in situ10.1ALB, F2
16duane retraction syndrome10.1ALB, F2
17chronic inflammatory demyelinating polyneuritis10.1ALB, F2
18isolated growth hormone deficiency10.1ALB, GPT
19not otherwise specified 3-mga-uria type10.1GPT, SLC17A5
20angelucci's syndrome10.1ALB, F2
21pancreatitis10.1
22autonomic peripheral neuropathy10.1ABCB4, ALB
23ovarian papillary cystadenoma10.1ALB, F2
24myopia10.1ALB, F2
25bladder sarcoma10.1ALB, GPT
26eagle syndrome10.1ALB, F2
27acute proliferative glomerulonephritis10.1F2, GPT, SLC17A5
28atrophic vulva10.1ALB, F2
29cholecystolithiasis10.1
30hereditary hemorrhagic telangiectasia10.0F2, GPT, SLC17A5
31cholecystitis10.0
32klinefelter's syndrome10.0ALB, ALPP
33chronic rheumatic pericarditis10.0ABCB4, ALB, SLC17A5
34primary pigmented nodular adrenocortical disease10.0ABCB4, UGT1A1
35benign deep fibrous histiocytoma10.0ALB, F2, GPT
36hemolytic-uremic syndrome10.0ALB, F2, GPT
37fiedler's myocarditis10.0ALB, F2, GPT
38heart aneurysm10.0ABCB4, ALB, F2
39acute cholangitis10.0
40capillary hemangioma10.0ALB, F2
41infiltrating ureter transitional cell carcinoma10.0ALB, F2, SLC17A5
42anal fistula10.0ALB, F2, SLC17A5
43ischemic optic neuropathy10.0ALB, F2
44orbital cancer10.0CTSC, SOBP
45fallopian tube leiomyosarcoma9.9ALB, F2, GPT, GUSB
46gastrointestinal adenoma9.9ABCB4, ALB, F2, GPT
47bacterial meningitis9.9ABCB4, ALB, F2, GPT
48female infertility of uterine origin9.9ALB, F2, GPT, SLC17A5
49retinal arterial macroaneurysm with supravalvular pulmonic stenosis9.9ALB, F2, GPT, SLC17A5
50acute monocytic leukemia9.9ALB, F2, GPT, SLC17A5

Graphical network of the top 20 diseases related to Choledocholithiasis:



Diseases related to choledocholithiasis

Symptoms & Phenotypes for Choledocholithiasis

About this section

Drugs & Therapeutics for Choledocholithiasis

About this section

Drugs for Choledocholithiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 41)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
MeperidineapprovedPhase 47557-42-14058
Synonyms:
1-Methyl-4-phenyl-4-piperidinecarboxylic acid ethyl ester
1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester
1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester [German]
1-Methyl-4-phenylisonipecotic acid, ethyl ester
1-Methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester
4-Carbethoxy-1-methyl-4-phenylpiperidine
4-Piperidinecarboxylic acid, 1-methyl-4-phenyl-, ethyl ester
50-13-5 (hydrochloride)
57-42-1
610593_ALDRICH
610593_FLUKA
AC1L1HBJ
C07128
CHEBI:122528
CHEMBL607
CID4058
D008614
D08343
DB00454
DEA No. 9230
Demarol
Demerol
DivK1c_000983
Dolcontral
Dolosal
Dolsin
EINECS 200-329-1
Ethyl 1-methyl-4-phenylisonipecotate
Ethyl 1-methyl-4-phenylpiperidine-4-carboxylate
HSDB 3116
IDI1_000983
Isonipecain
Isonipecaine
Isonipecaïne
Isonipecotic acid, 1-methyl-4-phenyl-, ethyl ester
KBio1_000983
 
L000908
LS-85121
Lidol
Lydol
Meperidine
Meperidine solution
Meperidol
Methyl phenylpiperidine carbonic acid ethyl ester
MolPort-001-785-564
N-Methyl-4-phenyl-4-carbethoxypiperidine
NINDS_000983
Nemerol
Operidine EPJ I
Operidine EPJ-I
Pethanol
Pethidin
Pethidine
Pethidine (INN)
Pethidine DBL
Pethidine DBL (TN)
Pethidine dbl
Pethidineter
Pethidinum
Pethidinum [INN-Latin]
Petidina
Petidina [INN-Spanish]
Petydyna
Petydyna [Polish]
Phetidine
Piperosal
Pipersal
Péthidine
Sauteralgyl
Spasmedal
Spasmodolin
UNII-9E338QE28F
YIsonipecotic acid, 1-methyl-4-phenyl-, ethyl ester (8CI)
meperidine
2
EtomidateapprovedPhase 46533125-97-236339, 667484
Synonyms:
(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate
(+)-Etomidate
(+)-ethyl 1-(α-methylbenzyl)imidazole-5-carboxylate
(+)-etomidate
(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester
(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester
(d)-Etomidate
1-(1-Phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester
1-(1-Phenylethyl)-imidazole-5-carboxylic acid, ethyl ester
1-(alpha-Methylbenzyl)-1H-imidazole-5-carboxylic acid ethyl ester
15301-65-2
1H-Imidazole-5-carboxylic acid, 1-((1R)-1-phenylethyl)-, ethyl ester
3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester
3-(1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester
33125-97-2
AC-5898
AC1L1VLF
AC1Q34BV
AC1Q64LP
AKOS000548952
Absele
Amidate
Amidate (TN)
Amidate (pharmaceutical)
Amidate, Etomidate
BAS 01947657
BRN 0665833
C07522
C14H16N2O2
CHEBI:129025
CHEMBL23731
CID36339
CPD000010931
D-Etomidate
D005045
D00548
 
DB00292
EINECS 251-385-9
Ethnor
Ethomidate
Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate
Etomidate
Etomidate (USAN/INN)
Etomidate [USAN:BAN:INN]
Etomidato
Etomidato [INN-Spanish]
Etomidatum
Etomidatum [INN-Latin]
Etomidic acid
HMS1571A04
HMS1612G10
HMS2093P17
Hypnomidate
LS-78232
MLS000034952
MLS001240191
MolPort-000-917-569
Prestwick0_001041
Prestwick1_001041
Prestwick2_001041
R 16659
R 26490
R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate
R-26490
R26490
Radenarcon
Radenarkon
S1329_Selleck
SAM002548930
SBB066197
SMR000010931
SPBio_002901
UNII-Z22628B598
ethyl 3-(1-phenylethyl)imidazole-4-carboxylate
3
Midazolamapproved, illicitPhase 472359467-70-84192
Synonyms:
4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate
59467-70-8
8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5a][1,4]benzodiazepine hydrochloride
8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine
8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine
AC-18749
AC1L1HMA
BIDD:GT0647
BRN 0625572
Buccolam
C07524
C18H13ClFN3
CHEMBL655
CID4192
D00550
DB00683
DEA No. 2884
Dazolam
Dea No. 2884
 
Dormicum
Dormicum (TN)
EINECS 261-774-5
LS-77780
Midanium
Midazolam
Midazolam (JAN/INN)
Midazolam Base
Midazolam Hcl
Midazolam [INN:BAN:JAN]
Midazolamum
Midazolamum [INN-Latin]
Midosed
MolPort-003-849-219
NCGC00168254-01
Ro 21-3981
TL8003787
UC429_SIGMA
UNII-R60L0SM5BC
Versed
ZINC00001732
midazolam
nchembio747-comp32
4
Ursodeoxycholic acidapproved, investigationalPhase 497128-13-231401
Synonyms:
(3a,5b,7b)-3,7-dihydroxy-cholan-24-oate
(3a,5b,7b)-3,7-dihydroxy-cholan-24-oic acid
(3a,5b,7b)-3,7-dihydroxycholan-24-oic acid
(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid
(3alpha,5beta,7beta,8xi)-3,7-dihydroxycholan-24-oic acid
(3α,5β,7β)-3,7-dihydroxycholan-24-oic acid
(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
128-13-2
17-beta-(1-Methyl-3-carboxypropyl)etiocholane-3-alpha,7-beta-diol
3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic Acid
3,7-Dihydroxycholan-24-oic acid
3-alpha,7-beta-Dihydroxy-5-beta-cholanoic acid
3-alpha,7-beta-Dihydroxycholanic acid
3-alpha,7-beta-Dioxycholanic acid
3a,7b-Dihydroxy-5b-cholan-24-oate
3a,7b-Dihydroxy-5b-cholan-24-oic acid
3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid
3alpha,7beta-Dihydroxy-5beta-cholanic acid
4-10-00-01604 (Beilstein Handbook Reference)
50809-41-1
5beta-Cholan-24-oic acid-3alpha,7beta-diol
5beta-Cholanic Acid-3alpha,7beta-diol
7-beta-Hydroxylithocholic acid
7beta-Hydroxylithocholic acid
80225-86-1
AB00513977
AC-18919
AC-2081
AC1L1LJH
Acide ursodesoxycholique
Acide ursodesoxycholique [INN-French]
Acido ursodeossicolico
Acido ursodeossicolico [Italian]
Acido ursodeoxicolico
Acido ursodeoxicolico [INN-Spanish]
Acidum ursodeoxycholicum
Acidum ursodeoxycholicum [INN-Latin]
Actigall
Actigall (TN)
Antigall
Arsacol
BB_NC-2372
BPBio1_001052
BRN 3219888
BSPBio_000956
C07880
C24H40O4
CCRIS 5502
CHEBI:9907
CHEMBL1551
CHEMBL73390
CID11516715
CID31401
CPD-10534
CPD000058403
Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-beta)- (9CI)
Cholit-ursan
D00734
DB01586
Delursan
Deoxyursocholic Acid
Destolit
Deursil
Dom-ursodiol c
EINECS 204-879-3
HMS1570P18
 
ISO-URSODEOXYCHOLIC ACID
IU5
LMST04010033
LS-53033
Litursol
Lyeton
MLS000028461
MLS001066373
MolPort-001-794-630
MolPort-005-932-884
NCGC00179363-01
NCI60_028904
NSC 657950
NSC 683769
PHL-ursodiol c
PMS-ursodiol c
Peptarom
Prestwick0_000958
Prestwick1_000958
Prestwick2_000958
Prestwick3_000958
S1643_Selleck
SAM002264653
SMP2_000012
SMR000058403
SPBio_003105
Sodium Ursodeoxycholate
Solutrat
U-9000
U0030
U5127_SIGMA
UDCA
UDCS
UNII-724L30Y2QR
URSODEOXYCHOLIC ACID
UrSO
Urosdesoxycholate
Urosdesoxycholic acid
Urosiol
Ursacholic Acid
Ursacol
Urso
Urso (TN)
Urso 250
Urso DS
Urso Forte
Ursobilin
Ursochol
Ursodamor
Ursodeoxy cholic acid
Ursodeoxycholate
Ursodeoxycholic acid
Ursodeoxycholic acid (JP15/INN)
Ursodeoxycholic acid, UDCA, Ursosan, Ursofalk, Urso Forte, Udiliv, Ursodiol
Ursodeoxycholicacid
Ursodesoxycholic acid
Ursodexycholate
Ursodexycholic Acid
Ursodexycholic acid
Ursodiol
Ursodiol (USP)
Ursodiol [USAN]
Ursofalk
Ursolvan
Ursosan
chenodeoxycholic acid
ursodeoxycholate
ursodiol
5Neurotransmitter AgentsPhase 418340
6NarcoticsPhase 43646
7Psychotropic DrugsPhase 46430
8Adjuvants, AnesthesiaPhase 41674
9Cholagogues and CholereticsPhase 4130
10Tranquilizing AgentsPhase 44265
11Peripheral Nervous System AgentsPhase 423689
12Gastrointestinal AgentsPhase 48402
13Anesthetics, GeneralPhase 42934
14AnestheticsPhase 49596
15Analgesics, OpioidPhase 43238
16Hypnotics and SedativesPhase 42616
17Anesthetics, IntravenousPhase 42538
18AnalgesicsPhase 411733
19GABA ModulatorsPhase 4904
20GABA AgentsPhase 41684
21Central Nervous System DepressantsPhase 413403
22Anti-Anxiety AgentsPhase 41885
23
Chlorhexidineapproved, vet_approved49955-56-19552079, 2713
Synonyms:
1,1 inverted exclamation marka-Hexamethylenebis[5-(4-chlorophenyl)biguanide]
1,1'-Hexamethylene bis(5-(P-chlorophenyl)biguanide)
1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide)
1,1'-Hexamethylenebis(5-(p-chlorophenyl)biguanide)
1,1'-Hexamethylenebis[5-(4-chlorophenyl)biguanide
1,6-Bis(5-(p-chlorophenyl)biguandino)hexane
1,6-Bis(p-chlorophenyldiguanido)hexane
1,6-Di(4'-chlorophenyldiguanido)hexane
1,6-Di(N-p-chlorophenyldiguanido)hexane
24798_FLUKA
282227_ALDRICH
348031_ALDRICH
4-12-00-01201 (Beilstein Handbook Reference)
55-56-1
AB00053427
AB1003159
AVAGARD
BPBio1_000272
BRN 2826432
BSPBio_000246
BSPBio_001977
C06902
C22H30Cl2N10
CAS-55-56-1
CCRIS 9230
CHEBI:3614
CHEMBL790
CID9552079
Chlorhexidin
Chlorhexidin [Czech]
Chlorhexidine
Chlorhexidine (INN)
Chlorhexidine Base
Chlorhexidine [INN:BAN]
Chlorhexidine gluconate
Chlorhexidinum
Chlorhexidinum [INN-Latin]
Cloresidina
Cloresidina [DCIT]
Clorhexidina
Clorhexidina [INN-Spanish]
D07668
DB00878
Decanoylacetaldehyde Sodium Sulfide
Dentisept [veterinary]
Dentisept [veterinary] (TN)
DivK1c_000761
EINECS 200-238-7
Fimeil
HMS1568M08
HSDB 7196
Hexadol
Hibiclens
Hibispray
Hibistat
I06-0621
I14-0050
IDI1_000761
 
KBio1_000761
KBio2_000717
KBio2_003285
KBio2_005853
KBio3_001197
KBioGR_000774
KBioSS_000717
LS-43917
Lisium (*Dihydrochloride*)
MK-412A
MLS001332387
MLS001332388
MLS002154209
Merfen-incolore
Merfen-incolore (TN)
MolPort-002-541-741
N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)]
N,N''''-hexane-1,6-diylbis[N'-(4-chlorophenyl)(imidodicarbonimidic diamide)]
N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradeca- nediimidamide
N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
N,N'-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
NCGC00016246-01
NCGC00091025-01
NCGC00091025-02
NINDS_000761
NSC526936
Nolvasan
Nolvasan (*Diacetate*)
Novalsan
Oro-Clense
Peridex
Periogard
Prestwick0_000143
Prestwick1_000143
Prestwick2_000143
Prestwick3_000143
Prestwick_53
QTL1_000020
Rotersept
SMR000857146
SPBio_000210
SPBio_002185
STK089248
STOCK1S-18831
Savloclens
Savlon babycare
Sebidin A
Sodium Houttuyfonamide
Soretol
Spectrum2_000135
Spectrum3_000339
Spectrum4_000277
Spectrum5_001322
Spectrum_000237
Sterido
Sterilon
Superspray
Tubulicid
UNII-R4KO0DY52L
chlorhexidine
24
Cefotaximeapproved3663527-52-6456256, 5742673
Synonyms:
(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
60846-21-1
63527-52-6
63527-53-7
64485-93-4 (mono-hydrochloride salt)
AC-217
AC1L1E42
AC1L9UKL
AC1NSF5T
AC1NSF6T
AC1NUIF8
AC1NX3QV
AC1NZU9Q
AC1O712I
AC1O7G8N
AC1OC9NB
AKOS003286450
BIDD:GT0681
BPBio1_000240
BRD-K78364995-236-03-5
BRD-K99586414-236-02-3
BSPBio_000218
BSPBio_001961
C06885
C16H17N5O7S2
CE3
CHEBI:204928
CHEMBL102
CID2632
CID456256
CID5361298
CID5361354
CID5479527
CID5742673
CID5916965
CID6540461
CID6604086
CID6914272
CID7566336
CID9868614
Cefotaxim
Cefotaxim Hikma
Cefotaxim Hikma (TN)
Cefotaxima
Cefotaxima [INN-Spanish]
 
Cefotaxime (INN)
Cefotaxime [INN:BAN]
Cefotaxime acid
Cefotaxime sodium
Cefotaximum
Cefotaximum [INN-Latin]
Cephotaxim
Cephotaxime
Claforan
Claforan (*Sodium salt*)
Céfotaxime
D07647
DB00493
DivK1c_000767
EINECS 264-299-1
HMS2090M11
IDI1_000767
KBio1_000767
KBio2_000548
KBio2_003116
KBio2_005684
KBio3_001181
KBioGR_000736
KBioSS_000548
Klaforan
LS-149920
LS-187246
Lopac0_000278
MolPort-002-339-742
MolPort-005-934-578
MolPort-006-834-754
NCGC00021126-01
NINDS_000767
Prestwick0_000139
Prestwick1_000139
Prestwick2_000139
Prestwick3_000139
RU 24662
Ru-24756
SPBio_000138
SPBio_002157
STK383264
Spectrum2_000119
Spectrum3_000331
Spectrum4_000268
Spectrum5_000667
Spectrum_000108
UNII-N2GI8B1GK7
cefotaxime
25
Cefoxitinapproved3635607-66-0441199
Synonyms:
(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-3-[(carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7S)-3-{[(aminocarbonyl)oxy]methyl}-7-(methyloxy)-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
3-[(carbamoyloxy)methyl]-7alpha-methoxy-7beta-[(2-thienylacetyl)amino]-3,4-didehydrocepham-4-carboxylate
3-[(carbamoyloxy)methyl]-7alpha-methoxy-7beta-[(thiophen-2-yl)acetamido]-3,4-didehydrocepham-4-carboxylic acid
33564-30-6
35607-66-0
AB00513931
AC-1303
AC1L9AQF
AC1L9SPP
BIDD:GT0505
BPBio1_000863
BSPBio_000783
BSPBio_003101
C06887
C08106
CEFOXITIN SODIUM
CFX
CHEBI:209807
CHEBI:53655
CHEMBL1200530
CHEMBL996
CID441199
CID441392
CPD-9233
CPD000058809
Cefoxitin
Cefoxitin (USAN/INN)
Cefoxitin sodium (JAN/USP)
Cefoxitin sodium salt
Cefoxitina
Cefoxitine
Cefoxitinum
Ceftoxitin
Cephoxitin
D00913
D02345
DB01331
 
DivK1c_000576
HMS1570H05
HMS1921F14
HMS2092P11
HMS501M18
IDI1_000576
KBio1_000576
KBio2_001879
KBio2_004447
KBio2_007015
KBio3_002601
KBioGR_000626
KBioSS_001879
MLS000028557
MLS001076334
MLS002222151
Mefoxin
Mefoxin (TN)
Mefoxitin
MolPort-003-666-398
NCGC00093351-02
NCGC00093351-03
NINDS_000576
Prestwick0_000832
Prestwick1_000832
Prestwick2_000832
Prestwick3_000832
Prestwick_12
Rephoxitin
SAM002564251
SMR000058809
SPBio_000771
SPBio_002704
SPECTRUM1502031
Spectrum 001399
Spectrum2_000676
Spectrum3_001491
Spectrum4_000153
Spectrum5_001145
Spectrum_001399
ZINC03830449
cefoxitin
26Plasminogen InactivatorsEarly Phase 110
27Tissue Plasminogen ActivatorEarly Phase 1238
28PlasminogenEarly Phase 1242
29Plasminogen Activator Inhibitor 1Early Phase 129
30Anti-Bacterial Agents11226
31Antibiotics, Antitubercular7180
32Disinfectants582
33glucagon478
34Chlorhexidine gluconate499
35Glucagon-Like Peptide 1715
36Anti-Infective Agents, Local1880
37Anti-Infective Agents22062
38Scopolamine hydrobromide72114-49-8
39Butylscopolammonium Bromide72
40Cephalosporins168
41Antitubercular Agents1343

Interventional clinical trials:

(show all 40)
idNameStatusNCT IDPhase
1Etomidate vs. Midazolam for Sedation During ERCPCompletedNCT02027311Phase 4
2UDCA for Symptomatic Gallstone DiseaseCompletedNCT00161083Phase 4
3Endoscopic Treatment of Difficult Bile Duct Stones: Spyglass + EHL x Balloon Dilation of the PapillaRecruitingNCT02703077Phase 4
4Comparison of Endoscopic Sphincterotomy Plus Large-balloon Dilatation and Conventional Treatment for Large CBD StonesCompletedNCT02592811Phase 3
5Magnetic Resonance Cholangiopancreatography Versus Endoscopic Retrograde Cholangiopancreatography in the Approach to Patients With Suspected Biliary ObstructionTerminatedNCT01424657Phase 3
6Laparoendoscopic Rendez Vous Versus Standard Two Stage Approach for the Management of Cholelithiasis/CholedocholithiasisUnknown statusNCT00416234
7A Prospective Randomized Study Comparing Different Dilation Durations for Endoscopic Papillary Balloon DilatationUnknown statusNCT00451581
8Comparison of Papillary Balloon Dilatation Vs.Sphincterotomy for Lithotripsy in Difficult Sphincterotomy or Distal CBD TaperingUnknown statusNCT00329888
9Prospective Study to Investigate the Frequency of Possible Bacterial Entry Into the Bloodstream (Bacteremia) and Infectious Complications Associated With the Use of the Spyglass Cholangioscopy System During ERCP (Endoscopic Retrograde CholangiopancreatogrUnknown statusNCT01414400
10Prospective Validation of "Cholecystectomy First" Strategy for Gallstone MigrationUnknown statusNCT02461147
11Timing of Laparoscopic Cholecystectomy After Endoscopic Retrograde Cholangiography for Acute Biliary PancreatitisUnknown statusNCT01687959Early Phase 1
12Laser Versus Mechanical Lithotripsy of Bile Duct StonesCompletedNCT01759979
13Randomized Trial of ERCP Then Laparoscopic Cholecystectomy vs. Laparoscopic Cholecystectomy Plus Laparoscopic Common Bile Duct Exploration in Patients With Likely CholedocholithiasisCompletedNCT00807729
14EUS Guided ERCP in Bile Duct Stone RemovalCompletedNCT02870686
15Left Lateral Position and Prone Position for Endoscopic Retrograde CholangiopancreatographyCompletedNCT02594475
16Effect of 8.5 F Plastic Stent Without Proximal Flap on Prevention of Post-ERCP CholangitisCompletedNCT02594891
17Study of Endoscopic Sphincterotomy With Needle Knife Papillotome in Patients of Ampullary Impacted StoneCompletedNCT00173368
18Laryngeal Mask Airway Supreme Versus the Tracheal Tube as an Airway Device in Elective Laparoscopic CholecystectomyCompletedNCT02037958
19Comparison Between Pre and Intraoperative ERCP in Treatment of Common Bile Duct StonesCompletedNCT01046552
20Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBDCompletedNCT01673269
21Prospective Multicenter Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall StonesCompletedNCT01683240
22Loop-tipped Guidewire in Selective Biliary CannulationCompletedNCT02028845
23Routine Bile Collection for Microbiological Analysis During CholangiographyCompletedNCT01003782
24Cytological Evaluation of Biliary Epithelium After Endoscopic SphincterotomyCompletedNCT01135732
25Trial Comparing Pain in Single-incision Laparoscopic Cholecystectomy Versus Conventional Laparoscopic CholecystectomyCompletedNCT01824186
26Incidence and Risk Factor of Post-ERCP Pancreatitis in Chronic PancreatitisCompletedNCT02781987
27Early EUS in Acute Biliary PancreatitisCompletedNCT02430285
28Comparison of LCBDE vs ERCP + LC for CholedocholithiasisRecruitingNCT02515474
29Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCPRecruitingNCT03074201
30Cholangiography Using Carbon Dioxide Versus Iodinated Contrast in ERCPRecruitingNCT02611453
31Microbiomes in Patients of Recurrent Common Bile Duct StonesRecruitingNCT03102281
32Optimization and Cost-effective Analysis of Secondary Biliary Stones' ManagementsRecruitingNCT02554097
33Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal DisordersRecruitingNCT01438385
34Los Angeles Prospective GI Biliary and EUS SeriesRecruitingNCT02196935
35The Clinical Characteristics of the Patients With Choledocholithiasis Without CholangitisEnrolling by invitationNCT02647593
36Direct Peroral Cholangioscopy by Using an Ultra-slim Upper EndoscopeEnrolling by invitationNCT02276157
37Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction PatientNot yet recruitingNCT02958059
38Study Investigating the Best Method of Treatment of Bile Duct Stones in Higher Risk PatientsTerminatedNCT00612846
39Management of Common Bile Duct (CBD) Stones at Laparoscopic CholecystectomyTerminatedNCT00124033
40Prospective Evaluation of the Covered Self-expandable Metal Stents (CSEMS) for Incomplete Biliary Stone ClearanceWithdrawnNCT01475864

Search NIH Clinical Center for Choledocholithiasis


Cochrane evidence based reviews: choledocholithiasis

Genetic Tests for Choledocholithiasis

About this section

Anatomical Context for Choledocholithiasis

About this section

MalaCards organs/tissues related to Choledocholithiasis:

36
Liver, Testes, Heart

Publications for Choledocholithiasis

About this section

Articles related to Choledocholithiasis:

(show top 50)    (show all 606)
idTitleAuthorsYear
1
Accuracy of ASGE criteria for the prediction of choledocholithiasis. (28071059)
2017
2
Laparoscopic Common Bile Duct Exploration Versus Open Approach in Cirrhotic Patients with Choledocholithiasis: A Retrospective Study. (27509535)
2016
3
Endoscopic management of choledocholithiasis and cholelithiasis in patients with cirrhosis. (26799755)
2016
4
Re: Endoscopic large balloon sphincteroplasty is a useful, safe adjunct for difficult to treat choledocholithiasis. (27910279)
2016
5
Utility of MRCP in clinical decision making of suspected choledocholithiasis: An institutional analysis and literature review. (27986260)
2016
6
Randomized clinical trial of intraoperative endoscopic retrograde cholangiopancreatography versus laparoscopic bile duct exploration in patients with choledocholithiasis. (27302483)
2016
7
Clinicopathological features of choledocholithiasis patients with high aminotransferase levels without cholangitis: Prospective comparative study. (27759652)
2016
8
Safe laparoscopic clearance of the common bile duct in emergently admitted patients with choledocholithiasis and cholangitis. (27212991)
2016
9
Choledocholithiasis: Evaluation, Treatment, and Outcomes. (27904245)
2016
10
Choledocholithiasis Without Cholelithiasis: Should the Gallbladder Stay or Should It Go? (26738738)
2016
11
A scoring system for the prediction of choledocholithiasis: a prospective cohort study. (26922689)
2016
12
Ultrathin choledochoscope improves outcomes in the treatment of gallstones and suspected choledocholithiasis. (27796141)
2016
13
Routine endoscopic ultrasound in moderate and indeterminate risk patients of suspected choledocholithiasis to avoid unwarranted ERCP: A prospective randomized blinded study. (27455855)
2016
14
Automated development of artificial neural networks for clinical purposes: Application for predicting the outcome of choledocholithiasis surgery. (27261565)
2016
15
Markedly Elevated Liver Enzymes in Choledocholithiasis in the absence of Hepatocellular Disease: Case Series and Literature Review. (27408902)
2016
16
Single-stage management with combined tri-endoscopic approach for concomitant cholecystolithiasis and choledocholithiasis. (27126621)
2016
17
Nationwide Assessment of Trends in Choledocholithiasis Management in the United States From 1998 to 2013. (27556900)
2016
18
Commentary on "Prospective Evaluation of the Clinical Features of Choledocholithiasis: Focus on Abdominal Pain". (27135725)
2016
19
Feasibility of nonradiation EUS-based ERCP in patients with uncomplicated choledocholithiasis (with video). (27040099)
2016
20
Intraoperative endoscopic nasobiliary drainage over primary closure of the common bile duct for choledocholithiasis combined with cholecystolithiasis: a cohort study of 211 cases. (27864721)
2016
21
Safety of immediate endoscopic sphincterotomy in acute suppurative cholangitis caused by choledocholithiasis. (26862368)
2016
22
Endoscopic versus laparoscopic treatment for choledocholithiasis: a prospective randomized controlled trial. (27857966)
2016
23
Advances of recurrent risk factors and management of choledocholithiasis. (27610642)
2016
24
No Stone Left Unturned: Using Choledocholithiasis to Open a Papillary Stenosis via a Choledochodudenal Fistula. (26958565)
2016
25
Factors and Outcomes Associated with MRCP Use prior to ERCP in Patients at High Risk for Choledocholithiasis. (27446845)
2016
26
Role of laparoscopic common bile duct exploration in the management of choledocholithiasis. (27231516)
2016
27
The utility and yield of endoscopic ultrasonography for suspected choledocholithiasis in common gastroenterology practice. (27556688)
2016
28
Laparo-endoscopic rendez-vous versus sequential "delayed" approach in patients with choledocholithiasis. (27981825)
2016
29
Prospective Evaluation of the Clinical Features of Choledocholithiasis: Focus on Abdominal Pain. (27135724)
2016
30
Endoscopic ultrasonography versus magnetic resonance cholangiopancreatography for suspected choledocholithiasis: Comments from the radiologists'. (27080612)
2016
31
Prevalence of Cholelithiasis and Choledocholithiasis in Morbidly Obese South Indian Patients and the Further Development of Biliary Calculus Disease After Sleeve Gastrectomy, Gastric Bypass and Mini Gastric Bypass. (26910024)
2016
32
Endoscopic ultrasound versus magnetic resonance cholangiopancreatography in suspected choledocholithiasis: A systematic review. (27080611)
2016
33
Surgical Management of Choledocholithiasis: A Disappearing Skill. (27556413)
2016
34
Single-session laparoscopic cholecystectomy and ERCP: a valid option for the management of choledocholithiasis. (26975235)
2016
35
Accuracy of ASGE criteria for the prediction of choledocholithiasis. (27063334)
2016
36
Scoring system to preoperatively predict choledocholithiasis. (27146040)
2016
37
LABEL procedure: Laser-Assisted Bile duct Exploration by Laparoendoscopy for choledocholithiasis: improving surgical outcomes and reducing technical failure. (27572062)
2016
38
Magnetic Resonance Cholangiopancreatography Still Plays a Role in the Preoperative Evaluation of Choledocholithiasis andA Biliary Pathology. (26922606)
2016
39
Endoscopic retrograde cholangiography for pediatric choledocholithiasis: Assessing the need for endoscopic intervention. (27298714)
2016
40
Same-day laparoscopic cholecystectomy and ERCP for choledocholithiasis. (27633358)
2016
41
The Usefulness of Early Endoscopic Ultrasonography in Acute Biliary Pancreatitis with Undetectable Choledocholithiasis on Multidetector Computed Tomography. (27780944)
2016
42
Severe Elevation of Liver Tests in Choledocholithiasis: An Uncommon Occurrence With Important Clinical Implications. (27466169)
2016
43
Use of an esophageal stent for successful treatment of significant choledocholithiasis to facilitate direct cholangioscopy. (27102830)
2016
44
A Randomized, Clinical Trial Involving Different Surgical Methods Affecting the Sphincter of Oddi in Patients With Choledocholithiasis. (27031649)
2016
45
The value of magnetic resonance cholangiopancreatography for the exclusion of choledocholithiasis. (27181286)
2016
46
Accuracy of scoring systems for suspected choledocholithiasis: A 5-variable score system versus ASGE clinical guidelines. (27089986)
2016
47
The Efficacy of Clinical Predictors for Patients with Intermediate Risk of Choledocholithiasis. (27640085)
2016
48
An analysis of omitting biliary tract imaging in 668 subjects admitted to an acute care surgery service with biochemical evidence of choledocholithiasis. (26506555)
2015
49
Laparoscopic treatment of choledocholithiasis. (25882100)
2015
50
Detectability of Choledocholithiasis on CT: The Effect of Positive Intraduodenal Enteric Contrast on Portovenous Contrast-enhanced Studies. (26346009)
2015

Variations for Choledocholithiasis

About this section

Expression for genes affiliated with Choledocholithiasis

About this section
Search GEO for disease gene expression data for Choledocholithiasis.

Pathways for genes affiliated with Choledocholithiasis

About this section

Pathways related to Choledocholithiasis according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.5ALB, F2
29.3CTSC, GUSB, SLC17A5

GO Terms for genes affiliated with Choledocholithiasis

About this section

Cellular components related to Choledocholithiasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1endoplasmic reticulum lumenGO:00057889.7ALB, CTSC, F2
2extracellular spaceGO:00056158.4ALB, CTSC, F2, GPT, GUSB

Biological processes related to Choledocholithiasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cellular response to estradiol stimulusGO:007139210.2ABCB4, UGT1A1
2acute-phase responseGO:000695310.2F2, UGT1A1
3response to organic substanceGO:00100339.2ABCB4, CTSC, UGT1A1

Molecular functions related to Choledocholithiasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1pyridoxal phosphate bindingGO:00301709.7ALB, GPT

Sources for Choledocholithiasis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet